Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Yamashita

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Clinical Calcium|October 31, 2018
[Bone and calcium metabolism associated with malignancy. Endocrine therapy of breast cancer.]Hiroko Yamashita
World Journal of Clinical Oncology|December 18, 2015
Tumor biology in estrogen receptor-positive, human epidermal growth factor receptor type 2-negative breast cancer: Mind the menopausal statusHiroko Yamashita
International Journal of Clinical Oncology|October 24, 2008
Current research topics in endocrine therapy for breast cancerHiroko Yamashita
Breast Cancer (Tokyo, Japan)|December 3, 2002
The role of Stat5 in estrogen receptor-positive breast cancerHiroko Yamashita, Hirotaka Iwase
Journal of Plant Research|November 28, 2008
Chloroplasts do not have a polarity for light-induced accumulation movementHidenori Tsuboi, Hiroko Yamashita, Masamitsu Wada
Pediatric Pulmonology|March 31, 2007
NF-kappaB in the lungs of premature rabbits during mechanical ventilation--comparison between conventional mechanical ventilation (CMV) and high-frequency oscillation (HFO)Kunihiro Oba, Hiroko Yamashita, Aki Waragai, et al.
Oncogene|March 19, 2003
Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cellsHiroko Yamashita, Hirotaka Iwase, Tatsuya Toyama, et al.
Cancer Science|August 10, 2004
Dominant-negative Stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude miceHiroko Yamashita, Mariko Nishio, Yoshitaka Fujii, et al.
Anticancer Research|July 2, 2014
Prognostic significance of pre-treatment neutrophil: lymphocyte ratio in Japanese patients with breast cancerKiichiroh Nakano, Mitsuchika Hosoda, Mitsugu Yamamoto, et al.
The Journal of Biological Chemistry|August 31, 2007
Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulationYuichi Fujinaka, Karen Takane, Hiroko Yamashita, et al.
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Clinical Calcium|October 31, 2018
[Bone and calcium metabolism associated with malignancy. Endocrine therapy of breast cancer.]Hiroko Yamashita
World Journal of Clinical Oncology|December 18, 2015
Tumor biology in estrogen receptor-positive, human epidermal growth factor receptor type 2-negative breast cancer: Mind the menopausal statusHiroko Yamashita
International Journal of Clinical Oncology|October 24, 2008
Current research topics in endocrine therapy for breast cancerHiroko Yamashita
Breast Cancer (Tokyo, Japan)|December 3, 2002
The role of Stat5 in estrogen receptor-positive breast cancerHiroko Yamashita, Hirotaka Iwase
Journal of Plant Research|November 28, 2008
Chloroplasts do not have a polarity for light-induced accumulation movementHidenori Tsuboi, Hiroko Yamashita, Masamitsu Wada
Pediatric Pulmonology|March 31, 2007
NF-kappaB in the lungs of premature rabbits during mechanical ventilation--comparison between conventional mechanical ventilation (CMV) and high-frequency oscillation (HFO)Kunihiro Oba, Hiroko Yamashita, Aki Waragai, et al.
Oncogene|March 19, 2003
Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cellsHiroko Yamashita, Hirotaka Iwase, Tatsuya Toyama, et al.
Cancer Science|August 10, 2004
Dominant-negative Stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude miceHiroko Yamashita, Mariko Nishio, Yoshitaka Fujii, et al.
Anticancer Research|July 2, 2014
Prognostic significance of pre-treatment neutrophil: lymphocyte ratio in Japanese patients with breast cancerKiichiroh Nakano, Mitsuchika Hosoda, Mitsugu Yamamoto, et al.
The Journal of Biological Chemistry|August 31, 2007
Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulationYuichi Fujinaka, Karen Takane, Hiroko Yamashita, et al.
Pageof 15